298 related articles for article (PubMed ID: 24810045)
21. Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells.
Klubo-Gwiezdzinska J; Jensen K; Costello J; Patel A; Hoperia V; Bauer A; Burman KD; Wartofsky L; Vasko V
Endocr Relat Cancer; 2012 Jun; 19(3):447-56. PubMed ID: 22389381
[TBL] [Abstract][Full Text] [Related]
22. Metformin prevents BAFF activation of Erk1/2 from B-cell proliferation and survival by impeding mTOR-PTEN/Akt signaling pathway.
Chen X; Ma J; Yao Y; Zhu J; Zhou Z; Zhao R; Dong X; Gao W; Zhang S; Huang S; Chen L
Int Immunopharmacol; 2021 Jul; 96():107771. PubMed ID: 34004440
[TBL] [Abstract][Full Text] [Related]
23. Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells.
Perfeito R; Lázaro DF; Outeiro TF; Rego AC
Mol Cell Neurosci; 2014 Sep; 62():51-9. PubMed ID: 25109238
[TBL] [Abstract][Full Text] [Related]
24. Metformin sensitizes insulin signaling through AMPK-mediated PTEN down-regulation in preadipocyte 3T3-L1 cells.
Lee SK; Lee JO; Kim JH; Kim SJ; You GY; Moon JW; Jung JH; Park SH; Uhm KO; Park JM; Suh PG; Kim HS
J Cell Biochem; 2011 May; 112(5):1259-67. PubMed ID: 21465524
[TBL] [Abstract][Full Text] [Related]
25. Neuro-Protective Role of Metformin in Patients with Acute Stroke and Type 2 Diabetes Mellitus via AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Pathway and Oxidative Stress.
Zhao M; Li XW; Chen Z; Hao F; Tao SX; Yu HY; Cheng R; Liu H
Med Sci Monit; 2019 Mar; 25():2186-2194. PubMed ID: 30905926
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between PI3K and Ras pathways via protein phosphatase 2A in human ovarian clear cell carcinoma.
Takai M; Nakagawa T; Tanabe A; Terai Y; Ohmichi M; Asahi M
Cancer Biol Ther; 2015; 16(2):325-35. PubMed ID: 25756515
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the mammalian target of rapamycin complex 1 signaling pathway reduces itch behaviour in mice.
Obara I; Medrano MC; Signoret-Genest J; Jiménez-Díaz L; Géranton SM; Hunt SP
Pain; 2015 Aug; 156(8):1519-1529. PubMed ID: 25906350
[TBL] [Abstract][Full Text] [Related]
28. Metabolic regulation of neuronal plasticity by the energy sensor AMPK.
Potter WB; O'Riordan KJ; Barnett D; Osting SM; Wagoner M; Burger C; Roopra A
PLoS One; 2010 Feb; 5(2):e8996. PubMed ID: 20126541
[TBL] [Abstract][Full Text] [Related]
29. O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson's disease.
Wani WY; Ouyang X; Benavides GA; Redmann M; Cofield SS; Shacka JJ; Chatham JC; Darley-Usmar V; Zhang J
Mol Brain; 2017 Jul; 10(1):32. PubMed ID: 28724388
[TBL] [Abstract][Full Text] [Related]
30. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
31. AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.
Van Nostrand JL; Hellberg K; Luo EC; Van Nostrand EL; Dayn A; Yu J; Shokhirev MN; Dayn Y; Yeo GW; Shaw RJ
Genes Dev; 2020 Oct; 34(19-20):1330-1344. PubMed ID: 32912901
[TBL] [Abstract][Full Text] [Related]
32. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
Yan R; Zhang J; Park HJ; Park ES; Oh S; Zheng H; Junn E; Voronkov M; Stock JB; Mouradian MM
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E12053-E12062. PubMed ID: 30509990
[TBL] [Abstract][Full Text] [Related]
33. Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein.
Waxman EA; Giasson BI
J Neuropathol Exp Neurol; 2008 May; 67(5):402-16. PubMed ID: 18451726
[TBL] [Abstract][Full Text] [Related]
34. Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts.
Lipner MB; Marayati R; Deng Y; Wang X; Raftery L; O'Neil BH; Yeh JJ
PLoS One; 2016; 11(1):e0147113. PubMed ID: 26760500
[TBL] [Abstract][Full Text] [Related]
35. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.
Narayanan U; Nalavadi V; Nakamoto M; Thomas G; Ceman S; Bassell GJ; Warren ST
J Biol Chem; 2008 Jul; 283(27):18478-82. PubMed ID: 18474609
[TBL] [Abstract][Full Text] [Related]
36. Metformin prevents the pathological browning of subcutaneous white adipose tissue.
Auger C; Knuth CM; Abdullahi A; Samadi O; Parousis A; Jeschke MG
Mol Metab; 2019 Nov; 29():12-23. PubMed ID: 31668383
[TBL] [Abstract][Full Text] [Related]
37. Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium.
Xu C; Zhang H; Liu C; Zhu Y; Wang X; Gao W; Huang S; Chen L
Oncotarget; 2015 Aug; 6(25):21452-67. PubMed ID: 26046303
[TBL] [Abstract][Full Text] [Related]
38. mTORC1 signaling can regulate growth factor activation of p44/42 mitogen-activated protein kinases through protein phosphatase 2A.
Harwood FC; Shu L; Houghton PJ
J Biol Chem; 2008 Feb; 283(5):2575-85. PubMed ID: 18056704
[TBL] [Abstract][Full Text] [Related]
39. Metformin ameliorates the status epilepticus- induced hippocampal pathology through possible mTOR modulation.
Bojja SL; Medhi B; Anand S; Bhatia A; Joshi R; Minz RW
Inflammopharmacology; 2021 Feb; 29(1):137-151. PubMed ID: 33386490
[TBL] [Abstract][Full Text] [Related]
40. Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway.
Chaudhary SC; Kurundkar D; Elmets CA; Kopelovich L; Athar M
Photochem Photobiol; 2012; 88(5):1149-56. PubMed ID: 22540890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
